Jeanie Herbert | Senior Director of IR & Corporate Communications |
Daniel Browne | Co-Founder, President, CEO |
Tobin Schilke | CFO & Principal Accounting Officer |
Annabel Samimy | Stifel |
Ken Cacciatore | Cowen & Company |
Seamus Fernandez | Guggenheim |
David Amsellem | Piper Jaffray |
David Maris | Wells Fargo |
Tim Lugo | William Blair |
Douglas Tsao | H.C. Wainwright |
Welcome to the Revance Therapeutics Second Quarter 2019 Financial Results and Corporate Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, August 5, 2019. I would like to turn the conference call over to Jeanie Herbert, Senior Director of Investor Relations and Corporate Communications for Revance. Please go ahead.
Thank you, Michelle.